Study how methylphenidate works in ADHD
Treatments studied
Part of Mental health clinical trials.
This study looks at how methylphenidate (a common ADHD medicine) affects the body and brain in people with ADHD. You may be able to join if you have an ADHD diagnosis and meet specific health and medication-related requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clinical diagnosis of ADHD (including being AFAB).
- You can swallow tablets (pills by mouth).
- You have regular menstrual cycles.
- Your prior response to ADHD medication is good.
- You do not have intellectual disability or specific learning disabilities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether the medication methylphenidate (often used for ADHD) can help people who have both ADHD and an addiction. It aims to see if the medicine is safe and works well for people with both conditions.
This trial studies whether a genetic difference called “carboxylesterase 1” changes how methylphenidate (a common ADHD medicine) works for children with ADHD. It’s a single-dose test, meant to help understand why some children respond differently to ADHD medication.
This study compares stimulant and non-stimulant ADHD medicines in kids who have not taken ADHD medication before. It also studies how these treatments affect brain “reward” processes, which may be linked to substance-use risk.
This study uses brain imaging (MRI) to see how methylphenidate affects brain activity in people with ADHD. It may help doctors better understand how this medicine works and who benefits most.
This trial tests whether methylphenidate (a stimulant medicine) helps adults with attention-deficit/hyperactivity disorder (ADHD). It is checking safety and effectiveness for people who can take the immediate-release form of the medicine.
This study looks at how the brain's electrical activity may predict whether a child with ADHD will respond well to methylphenidate (Ritalin). It aims to find biological markers that could help doctors choose the right treatment sooner.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.